01—Abstract
Summary
Summary of the 8-K filed May 29, 2026. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation held its 2026 Annual Meeting of Shareholders on May 27, 2026, and this Item 5.07 filing reports the final voting results.
Shareholders elected all twelve director nominees, each to serve until the next annual meeting or until a successor is duly elected or qualified, or until earlier resignation or removal. Each nominee received more votes FOR than AGAINST, with Saumya Sutaria (72,297,676 FOR; 2,036,933 AGAINST) and J. Robert Kerrey (71,837,362 FOR; 2,539,818 AGAINST) showing the largest AGAINST counts among the directors.
Shareholders also approved, on an advisory basis, the company's executive compensation, with 62,554,346 votes FOR, 11,817,273 AGAINST, and 39,895 ABSTAIN, plus 5,510,667 broker non-votes. The say-on-pay vote had considerably more AGAINST votes than the director votes, which is the item most worth attention from investors. Shareholders ratified the selection of Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2026, with 79,422,386 votes FOR, 470,477 AGAINST, and 29,318 ABSTAIN.
02—Key points
Key Highlights
- Annual Meeting of Shareholders held May 27, 2026, with final voting results reported under Item 5.07.
- All twelve director nominees were elected, including Saumya Sutaria, J. Robert Kerrey, Vineeta Agarwala, James L. Bierman, Roy Blunt, Richard W. Fisher, Meghan M. FitzGerald, Cecil D. Haney, Christopher S. Lynch, Richard J. Mark, Tammy Romo, and Nadja Y. West.
- Director vote tallies ranged from 73,162,461 to 73,793,459 FOR votes for most nominees, with Saumya Sutaria (72,297,676 FOR) and J. Robert Kerrey (71,837,362 FOR) receiving the lowest FOR counts.
- Advisory say-on-pay proposal approved, with 62,554,346 FOR and 11,817,273 AGAINST votes, a notably higher AGAINST count than the director votes.
- Deloitte & Touche LLP ratified as independent registered public accountants for the year ending December 31, 2026, with 79,422,386 FOR and 470,477 AGAINST votes.
- Broker non-votes of 5,510,667 were recorded on the director and say-on-pay proposals.
03—Questions
Frequently Asked Questions
When and where was the 2026 Annual Meeting held?
The filing states the 2026 Annual Meeting of Shareholders was held on May 27, 2026. It does not state the location.
Were all director nominees elected?
Yes. The filing reports that shareholders elected all twelve listed directors, each to serve until the next annual meeting or until a successor is duly elected or qualified, or until earlier resignation or removal.
How did shareholders vote on executive compensation?
Shareholders approved the executive compensation on an advisory basis, with 62,554,346 votes FOR, 11,817,273 AGAINST, 39,895 ABSTAIN, and 5,510,667 broker non-votes.
Which auditor did shareholders ratify?
Shareholders ratified the selection of Deloitte & Touche LLP as the company's independent registered public accountants for the year ending December 31, 2026, with 79,422,386 votes FOR, 470,477 AGAINST, and 29,318 ABSTAIN.
Which directors received the most opposition?
Among the directors, Saumya Sutaria received 2,036,933 AGAINST votes and J. Robert Kerrey received 2,539,818 AGAINST votes, the two highest AGAINST counts reported. Their FOR totals were 72,297,676 and 71,837,362, respectively, the lowest FOR totals among the nominees.
04—Continue